You have 6 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Herpesvirus 2, Human

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Sarasota, Nashville (AC699)

Recruiting
  • Breast Cancer
  • Sarasota, Florida
  • +1 more
Jan 3, 2023

Danon Disease Trial in La Jolla, Philadelphia (RP-A501)

Recruiting
  • Danon Disease
  • RP-A501
  • La Jolla, California
  • +1 more
Oct 17, 2023

Type 2 Diabetes Trial in Toulouse (blood samples, collection of body tissues, routine care procedure)

Not yet recruiting
  • Type 2 Diabetes
  • blood samples
  • +2 more
  • Toulouse, France
    Toulouse University Hospital
Jul 21, 2022

Prostate Cancer, Erectile Dysfunction Following Radical Prostatectomy Trial in Miami (BioDFence G3 Placental Tissue Membrane,

Not yet recruiting
  • Prostate Cancer
  • Erectile Dysfunction Following Radical Prostatectomy
  • BioDFence G3 Placental Tissue Membrane
  • Robot-Assisted Radical Prostatectomy
  • Miami, Florida
    University of Miami
Apr 24, 2023

Aortic Valve Stenosis Trial in Strasbourg (Myocardium biopsy)

Not yet recruiting
  • Aortic Valve Stenosis
  • Myocardium biopsy
  • Strasbourg, France
    Hôpitaux Universitaires de Strasbourg
Apr 13, 2023

Environmental and Genetic Determinants of NPC

Terminated
  • Nasopharyngeal Neoplasms
  • Herpesvirus 4, Human
    • Taipei City, Taiwan
    • +5 more
    Jun 3, 2020

    Breast Cancer Trial (Tucatinib, Doxil)

    Not yet recruiting
    • Breast Cancer
    • (no location specified)
    Feb 17, 2023

    Systemic Lupus Erythematosus Trial in Changchun (IL-2)

    Completed
    • Systemic Lupus Erythematosus
    • Changchun, Changchun/Jilin, China
      Sirui Yang
    Aug 16, 2022

    SARS CoV 2 Infection, SARS-CoV-2 Acute Respiratory Disease Trial in Bangkok (Human IgG1 anti-SARS-CoV-2 antibody cocktail,

    Completed
    • SARS CoV 2 Infection
    • SARS-CoV-2 Acute Respiratory Disease
    • Human IgG1 anti-SARS-CoV-2 antibody cocktail
    • Placebo
    • Bangkok, Thailand
      National Cancer Institute of Thailand
    Jul 5, 2022

    Healthy, Obese, Diabetes, Type 2 Trial in Boston (Exercise Intervention)

    Recruiting
    • Healthy
    • +2 more
    • Exercise Intervention
    • Boston, Massachusetts
      Joslin Diabetes Center
    Jan 4, 2023

    Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage

    Recruiting
    • Advanced Solid Tumor
    • Refractory Tumor
    • Radiotherapy
    • +4 more
    • Suzhou, China
      The Second Affiliated Hospital of SchoowUniversity
    Sep 14, 2023

    Central Insulin Resistance, Diabetes, Type 2, PreDiabetes Trial (Human nasal insulin, Placebo)

    Not yet recruiting
    • Central Insulin Resistance
    • +2 more
    • Human nasal insulin
    • Placebo
    • (no location specified)
    May 12, 2023

    Immunization, Efficacy, Human Papilloma Virus Trial in Galveston (9-valent HPV vaccine, 2 dose efficacy, 9-valent HPV vaccine, 3

    Recruiting
    • Immunization
    • +2 more
    • 9-valent HPV vaccine, 2 dose efficacy
    • 9-valent HPV vaccine, 3 doses standard timing
    • Galveston, Texas
      University of Texas Medical Branch
    Jan 30, 2023

    Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

    Recruiting
    • Hormone Receptor Positive HER-2 Negative Breast Cancer
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jun 12, 2023

    Cancer Trial in Lexington (Therapeutic Intervention)

    Recruiting
    • Cancer
    • Therapeutic Intervention
    • Lexington, Kentucky
      Markey Cancer Center, University of Kentucky
    Nov 18, 2022

    Intracranial Glioma, Metastatic Brain Tumor, Breast Cancer Trial in Detroit (1-(2-[18F]FLUOROETHYL)-L-Tryptophan)

    Recruiting
    • Intracranial Glioma
    • +3 more
    • Detroit, Michigan
      Karmanos Cancer Institute
    Sep 22, 2022

    COVID-19 Trial in Herston (UQSC2 Vaccine, NVX-CoV2373 vaccine)

    Not yet recruiting
    • COVID-19
    • UQSC2 Vaccine
    • NVX-CoV2373 vaccine
    • Herston, Queensland, Australia
      Q-Pharm Pty Ltd (Nucleus Network Brisbane)
    Mar 8, 2023

    Pancreatic Cancer Trial (PBP1510 (400mg/16mL), Gemcitabine (1000 mg/m^2))

    Not yet recruiting
    • Pancreatic Cancer
    • PBP1510 (400mg/16mL)
    • Gemcitabine (1000 mg/m^2)
    • (no location specified)
    Sep 27, 2022

    Studies of Human Herpesvirus 8 and Kaposi's Sarcoma in Sicily

    Completed
    • Kaposi s Sarcoma (KS)
      • Palermo, Italy
        Universita Degli Studi Di Palermo
      May 7, 2020

      HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

      Recruiting
      • HR+/HER2- Advanced Breast Cancer
      • Targeted Therapy
      • Beijing, Beijing, China
        National Cancer Center/National Clinical Research Center for Can
      Aug 1, 2023

      Leptomeningeal Disease, Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell Vaccine)

      Recruiting
      • Leptomeningeal Disease
      • +2 more
      • Dendritic Cell Vaccine
      • Tampa, Florida
        Moffitt Cancer Center
      Apr 11, 2023

      PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer Trial (RLY-5836, Fulvestrant, Palbociclib)

      Not yet recruiting
      • PIK3CA Mutation
      • +7 more
      • (no location specified)
      Mar 7, 2023

      Healthy Trial in Maastricht (Clenbuterol Hydrochloride, Placebos)

      Completed
      • Healthy
      • Clenbuterol Hydrochloride
      • Placebos
      • Maastricht, Limburg, Netherlands
        Maastricht University
      Nov 28, 2022

      Advanced Solid Tumor, Metastatic Solid Tumor Trial (DS-3939a)

      Not yet recruiting
      • Advanced Solid Tumor
      • Metastatic Solid Tumor
      • (no location specified)
      May 12, 2023

      Melanoma Trial in Beijing (OH2 injection, HX008 injection)

      Recruiting
      • Melanoma
      • OH2 injection
      • HX008 injection
      • Beijing, Beijing, China
        Peking University Cancer Hospital
      Jan 28, 2023